Debjani Pal
AeroLeads people directory · profile

Debjani Pal Email & Phone Number

Principal Scientist at Tasca Therapeutics
Location: Cambridge, Massachusetts, United States 9 work roles 3 schools
1 work email found @relaytx.com 3 phones found area 516 and 785 LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email d****@relaytx.com
Direct phone (516) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Principal Scientist
Location
Cambridge, Massachusetts, United States

Who is Debjani Pal? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Debjani Pal is listed as Principal Scientist at Tasca Therapeutics, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at relaytx.com, phone signal with area code 516, 785, and a matched LinkedIn profile for Debjani Pal.

Debjani Pal previously worked as Senior Scientist I at Relay Therapeutics and Scientist ll at Relay Therapeutics. Debjani Pal holds Doctor Of Philosophy (Ph.D.), Cell/Cellular And Molecular Biology from Stony Brook University.

Company email context

Email format at Tasca Therapeutics

This section adds company-level context without repeating Debjani Pal's masked contact details.

{first_initial}{last}@relaytx.com
86% confidence

AeroLeads found 1 current-domain work email signal for Debjani Pal. Compare company email patterns before reaching out.

Profile bio

About Debjani Pal

Cancer biologist with a primary interest in Target ID, Validation & Drug Discovery• Currently the biology and in vivo pharmacology lead of a multidisciplinary oncology program in pre-clinical drug discovery stage.• Previously: designed and lead the biology efforts of a multidisciplinary project in early discovery and hit finding stage. Also, lead biology and in vivo pharmacology efforts of a project at clinical development stage: Designed and executed in vitro and in vivo studies to demonstrate the mechanism of action and efficacy of a clinical stage drug in new indications.• 4 years of expertise in Target ID, Validation efforts in apoptosis pathway, E3-ubiquitin ligase, targeted protein degradation, functional genomic tools, and screening techniques (with Dr. William Sellers at Broad Institute).• 8 years of experience in signaling, genetic, and epigenetic regulation of cancer initiation, evolution, metastasis and drug resistance (with Dr Raffaella Sordella at CSHL).• Consistent track record of scientific excellence, as demonstrated by publications.• A thoughtful mentor helping junior scientists and colleagues develop their projects and careers.• Experience with managing multiple industry collaborations.

Listed skills include Biochemistry, Molecular Biology, Western Blotting, Pcr, and 19 others.

Current workplace

Debjani Pal's current company

Company context helps verify the profile and gives searchers a useful next step.

Tasca Therapeutics
Tasca Therapeutics
Principal Scientist
Cambridge, MA, US
AeroLeads page
9 roles

Debjani Pal work experience

A career timeline built from the work history available for this profile.

Scientist Ll

Cambridge, Ma, Us

• Served as the biology lead of a multidisciplinary project in early discovery and hit finding stage.• Served as the biology lead of a project at clinical development stage: Designed and executed in vitro and in vivo studies to demonstrate the mechanism of action and efficacy of a clinical stage drug in new indications.

Nov 2021 - Dec 2023

Postdoctoral Research Associate

Cambridge, Ma, Us

• Discovered a novel, druggable E3-ubiquitin ligase regulator of apoptosis: 1) Demonstrated the mechanism of action of the E3 by using biochemical, genomic, molecular biology and in vivo techniques. 2) Determined a peptide sequence able to inhibit the novel E3 leading to induction of apoptosis. 3) Identified biomarker and determined lineage specificity for synergism of the novel E3 with current BH3 mimetic therapeutics. 4) Collaborated with several academic labs and platforms at Broad Institute to perform experiments key to the project: Protein purification, BH3 profiling assay, IP/Mass Spec, TCR-T-cell mediated cytotoxicity assay.• Received 2021 - Harry J Lloyd Charitable Trust Melanoma Research Career Development Grant• Coordinated meetings and presented data at Pharma-Broad collaboration meetings.• Supervised, trained, and completed performance reviews of two junior scientists.Mentor: Dr. William R. Sellers

Oct 2017 - Nov 2021

Doctoral Student

Cold Spring Harbor, New York, Us

• Discovered a novel regulation of DNA double strand break repair pathway mediated by TGF-beta, causing tumor heterogeneity and drug resistance in NSCLC.• Studied function of novel TP53 exon-6 truncating mutations.• Studied epigenetic switch of drug resistant population in NSCLC• Created a rapid and tunable Cas9 stabilization system with precise editing ability. PhD Thesis advisor: Dr. Raffaella Sordella, 2012-2017

Feb 2012 - Oct 2017

Graduate Student In Molecular And Cellular Biology Program

Stony Brook, Ny, Us

• 2011-2011: Studied contribution of EGFR and PI3K activity in KRAS mutant pancreatic cancer progression (PI: Dr. Howard Crawford).• 2010-2011: TA for BIO311(DNA Recombination Lab) and BIO365(Biochem Lab).

Aug 2010 - May 2017

Graduate Research Assistant/ Teaching Assistant

Manhattan, Ks, Us

Characterized the role of a novel microtubule destabilizing factor termed CCDC69 in controlling the assembly of central spindles and the recruitment of midzone components.MS thesis advisor: Dr. Qize Wei

Aug 2008 - Jul 2010

Summer Project Trainee

Saha Institute Of Nuclear Physics, India

Worked on characterization of Heat stable Cyclin dependent Kinase Inhibitors fromLeishmania donovani with Dr. Partha Saha

May 2006 - Aug 2006
3 education records

Debjani Pal education

Doctor Of Philosophy (Ph.D.), Cell/Cellular And Molecular Biology

Stony Brook University

Ms, Biochemistry; Mentor Dr. Qize Wei

Kansas State University

Bachelor Of Science - Bs, Zoology(Honors), Chemistry, Botany

Bethune College
FAQ

Frequently asked questions about Debjani Pal

Quick answers generated from the profile data available on this page.

What company does Debjani Pal work for?

Debjani Pal works for Tasca Therapeutics.

What is Debjani Pal's role at Tasca Therapeutics?

Debjani Pal is listed as Principal Scientist at Tasca Therapeutics.

What is Debjani Pal's email address?

AeroLeads has found 1 work email signal at @relaytx.com for Debjani Pal at Tasca Therapeutics.

What is Debjani Pal's phone number?

AeroLeads has found 3 phone signal(s) with area code 516, 785 for Debjani Pal at Tasca Therapeutics.

Where is Debjani Pal based?

Debjani Pal is based in Cambridge, Massachusetts, United States while working with Tasca Therapeutics.

What companies has Debjani Pal worked for?

Debjani Pal has worked for Tasca Therapeutics, Relay Therapeutics, Broad Institute Of Mit And Harvard, Cold Spring Harbor Laboratory, and Stony Brook University.

How can I contact Debjani Pal?

You can use AeroLeads to view verified contact signals for Debjani Pal at Tasca Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Debjani Pal attend?

Debjani Pal holds Doctor Of Philosophy (Ph.D.), Cell/Cellular And Molecular Biology from Stony Brook University.

What skills is Debjani Pal known for?

Debjani Pal is listed with skills including Biochemistry, Molecular Biology, Western Blotting, Pcr, Cell Biology, Cancer Research, Protein Chemistry, and Protein Expression.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.